Management of corticosteroid-induced osteoporosis
Corticosteroid (CS) therapy is widely used in the treatment of rheumatic diseases. Osteoporosis remains one of its major complications. The risk of low bone mineral density (BMD) and fracture may be already increased in some of the rheumatic diseases, regardless of CS therapy. However, in spite of t...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Published: |
Oxford University Press
2002
|
| Subjects: |